Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash to Debt 0.07
ASNB's Cash to Debt is ranked lower than
67% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.07 vs. ASNB: 0.07 )
ASNB' s 10-Year Cash to Debt Range
Min: 0.04   Max: No Debt
Current: 0.07

Equity to Asset -0.06
ASNB's Equity to Asset is ranked lower than
68% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. ASNB: -0.06 )
ASNB' s 10-Year Equity to Asset Range
Min: -0.32   Max: 0.97
Current: -0.06

-0.32
0.97
F-Score: 5
Z-Score: -19.10
M-Score: -3.46
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -1.97
ASNB's Operating margin (%) is ranked lower than
67% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. ASNB: -1.97 )
ASNB' s 10-Year Operating margin (%) Range
Min: -366.67   Max: -6.81
Current: -1.97

-366.67
-6.81
Net-margin (%) -13.92
ASNB's Net-margin (%) is ranked lower than
67% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.99 vs. ASNB: -13.92 )
ASNB' s 10-Year Net-margin (%) Range
Min: -733.33   Max: 369.73
Current: -13.92

-733.33
369.73
ROE (%) -402.75
ASNB's ROE (%) is ranked lower than
69% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.72 vs. ASNB: -402.75 )
ASNB' s 10-Year ROE (%) Range
Min: -1635.04   Max: 186.38
Current: -402.75

-1635.04
186.38
ROA (%) -13.18
ASNB's ROA (%) is ranked lower than
67% of the 289 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.08 vs. ASNB: -13.18 )
ASNB' s 10-Year ROA (%) Range
Min: -121.43   Max: 99.96
Current: -13.18

-121.43
99.96
ROC (Joel Greenblatt) (%) -2.53
ASNB's ROC (Joel Greenblatt) (%) is ranked lower than
67% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.54 vs. ASNB: -2.53 )
ASNB' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1400   Max: -9
Current: -2.53

-1400
-9
Revenue Growth (%) 14.50
ASNB's Revenue Growth (%) is ranked lower than
74% of the 262 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. ASNB: 14.50 )
ASNB' s 10-Year Revenue Growth (%) Range
Min: -57.3   Max: 106.6
Current: 14.5

-57.3
106.6
EBITDA Growth (%) -100.00
ASNB's EBITDA Growth (%) is ranked lower than
87% of the 221 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. ASNB: -100.00 )
ASNB' s 10-Year EBITDA Growth (%) Range
Min: -100   Max: 49.4
Current: -100

-100
49.4
EPS Growth (%) -48.90
ASNB's EPS Growth (%) is ranked lower than
88% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.20 vs. ASNB: -48.90 )
ASNB' s 10-Year EPS Growth (%) Range
Min: -48.9   Max: 33.2
Current: -48.9

-48.9
33.2
» ASNB's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with ASNB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 0.30
ASNB's P/S is ranked lower than
64% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.74 vs. ASNB: 0.30 )
ASNB' s 10-Year P/S Range
Min: 0.11   Max: 50
Current: 0.3

0.11
50
EV-to-EBIT -44.59
ASNB's EV-to-EBIT is ranked lower than
64% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.42 vs. ASNB: -44.59 )
ASNB' s 10-Year EV-to-EBIT Range
Min: -71.3   Max: 0.5
Current: -44.59

-71.3
0.5
Current Ratio 0.70
ASNB's Current Ratio is ranked lower than
68% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.72 vs. ASNB: 0.70 )
ASNB' s 10-Year Current Ratio Range
Min: 0.67   Max: 32
Current: 0.7

0.67
32
Quick Ratio 0.47
ASNB's Quick Ratio is ranked lower than
68% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. ASNB: 0.47 )
ASNB' s 10-Year Quick Ratio Range
Min: 0.47   Max: 32
Current: 0.47

0.47
32

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.09
ASNB's Price/Median PS Value is ranked lower than
64% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.19 vs. ASNB: 0.09 )
ASNB' s 10-Year Price/Median PS Value Range
Min: 0.1   Max: 22.67
Current: 0.09

0.1
22.67
Earnings Yield (Greenblatt) -1.50
ASNB's Earnings Yield (Greenblatt) is ranked lower than
68% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.50 vs. ASNB: -1.50 )
ASNB' s 10-Year Earnings Yield (Greenblatt) Range
Min: 191.2   Max: 894.7
Current: -1.5

191.2
894.7

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
AdvanSource Biomaterials Corporation, formerly known as CardioTech International, Inc., was founded in 1993 as a subsidiary of PolyMedica Corporation. It develops polymer materials which provide critical characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating anatomical sites and disease states. Its edge technology, notably products such as ChronoFlex, ChronoSilTM, HydroMed, and HydroThane, has been developed to overcome a design and functional challenges. It also manufactures and sells its proprietary HydroThane polymers to medical device manufacturers that are evaluating HydroThane for use in their products. HydroThane is a thermoplastic, water-absorbing, polyurethane elastomer possessing properties which is suited for the complex requirements of a variety of catheters. In addition to its physical properties, HydroThane exhibits an inherent degree of bacterial resistance, clot resistance and biocompatibility. When hydrated, HydroThane has elastic properties similar to living tissue. The Company also manufactures specialty hydrophilic polyurethanes that are primarily sold to customers as part of exclusive arrangements.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK